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Abstract
Background—Rhinovirus is linked to asthma exacerbations and chronic obstructive pulmonary 
disease exacerbations in adults. The severity and rates of rhinovirus acute respiratory illnesses 
(ARI) in adults are uncertain.
Objectives—We determined rhinovirus-associated ARI rates in adults presenting for care in 
multiple settings and identified factors associated with rhinovirus detection.
Methods—This prospective, population-based cohort enrolled Tennessee residents ≥18 years old 
in the emergency department (ED), outpatient clinics, or hospitalized for ARI December 2008-
May 2010. Nasal/throat swabs were collected and tested for rhinovirus and other viruses by RT-
PCR. Rates of ED visits and hospitalizations were calculated and rhinovirus-positive and -negative 
patients were compared.
Results—Among 2351 enrollees, rhinovirus was detected in 247 (11%). There were 7 
rhinovirus-associated ED visits and 3 hospitalizations per 1000 adults annually. Patients with 
rhinovirus, compared to virus-negative ARI, were more likely to present with wheezing (odds 
ratio [OR] 1.7, 95% confidence interval [CI] 1.23-2.35, p<0.001), to be a current smoker (OR 
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2.31, CI 1.68-3.19) or live with a smoker (OR 1.72, CI 1.10-2.67), have a history of chronic 
respiratory disease (OR 1.61, CI 1.17-2.22), and were less likely to be hospitalized versus seen in 
the outpatient setting (OR 0.58, CI 0.41-0.83).
Conclusion—Rhinovirus is associated with a substantial number of ED visits and 
hospitalizations for ARI in adults. There may be modifiable factors that can reduce the likelihood 
of presenting with rhinovirus-associated ARI.
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Introduction
Human rhinoviruses, first identified in culture in 1956, are members of the Picornaviridae 
family(1, 2). More than 150 serotypes or genotypes of rhinovirus have been identified to 
date(1, 3-5), and most known serotypes fall into one of three main species: rhinovirus A, 
rhinovirus B, or rhinovirus C(6-20). Rhinoviruses are the most frequent cause of the 
common cold in adults and children. Rhinoviruses are also associated with lower respiratory 
illness(21-30) and with a significant burden of disease in infants and young children(21, 31).
Rhinoviruses are frequently associated with exacerbations of asthma and chronic obstructive 
pulmonary disease (COPD) in adults(22, 23, 26, 32-38). The recently described rhinovirus C 
has been associated with wheezing and more severe respiratory symptoms in children(39, 
40), but these findings have been inconsistent and data are limited in adults(41, 42). The 
impact of the novel rhinovirus C on US adults has not been established, and the association 
of rhinovirus C with asthma and COPD is unclear.
We analyzed a large, prospective cohort of US adults, originally recruited during an 
Influenza surveillance study, who presented to outpatient clinics, emergency departments 
(ED), or were hospitalized with ARI or fever. We sought to establish the role of rhinovirus 




Adults ≥18 years of age who were seen in the hospital, emergency department (ED), or 
outpatient clinics with acute respiratory symptoms or fever from December 2008 through 
May 2010 in middle Tennessee(43, 44)(43, 44) were invited to participate in an influenza 
surveillance study(43-46). Seasonal influenza surveillance began in 2008 and continued 
through 2011. The specific study months were selected for rhinovirus analyses since there 
was year-round enrollment during that period because of pandemic influenza, and 
rhinoviruses are known to be associated with symptomatic infections year-round. 
Enrollment was restricted to residents of Nashville, TN (Davidson County) and 11 
surrounding counties. Institutional Review Boards of the participating surveillance hospitals 
approved the study. Two to five days each week, study nurses identified patients at each 
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study site with ARI symptoms or fever/feverishness. When influenza was circulating, 
surveillance was performed 5 days per week. In the clinic and ED, only patients presenting 
during the day were enrolled. Hospitalized patients could be enrolled if they had been 
admitted within 24 hours. Written informed consent was obtained from the patient. 
Demographic and clinical information from each patient was collected on a standardized 
questionnaire(43). History of underlying medical conditions, health insurance status, 
symptom duration, past medical history, microbiology laboratory results, laboratory results, 
hospital course, and discharge diagnoses were obtained from the medical record. A 
maximum of 10 ICD-9 discharge diagnosis codes were recorded for each hospitalization. 
For the purposes of this study, patients were classified as having “obstructive wheezing 
illness” if the medical record documented physician-diagnosed asthma, COPD, or patient 
reported wheezing. After testing for influenza, samples were frozen for future use. If 
patients agreed to future use, samples were thawed for testing for human rhinovirus, in 
addition to respiratory syncytial virus (RSV)(44) and human metapneumovirus (MPV). (44, 
47)
Samples
At the time of enrollment, nasal and throat swabs were collected, combined into a single 
tube of transport media (Remel M4RT), transported immediately to the lab on ice, divided 
into aliquots and stored at −80°C until processed. RNA was extracted from 200 μl of 
medium on a Roche MagNApure LC automated nucleic acid extraction instrument and real-
time RT-PCR for the detection of rhinovirus was performed as previously described(48-51) 
using primers and probe sequences from a highly conserved human rhinovirus 5’-non-
coding region (NCR) capable of detecting all rhinovirus prototype strains(49). Samples 
positive for rhinovirus were then cloned and sequenced. A 548-nucleotide sequence which 
encompassed the VP4/VP2 region(51) was amplified, directly sequenced(52), and compared 
to published GenBank sequences to determine species. MPV and RSV were tested for by 
RT-PCR using primers/probes previously described(53, 54).
Statistical Analysis
Proportions of rhinovirus positive and rhinovirus subspecies samples were summarized by 
viral status, and by inpatient/outpatient/ED status. If a patient presented to the ED but was 
then hospitalized, they were included in the hospitalized group. Demographic and clinical 
variables were summarized using median and inter-quartile range (IQR) for continuous 
variables and counts/percentages for categorical variables. Logistic regression with 
restricted cubic splines for seasonal variation was used to provide time-smoothed estimates 
of the probability of rhinovirus positive and rhinovirus-C positive (among rhinovirus 
positive samples) across time. The number of ARI hospital and ED visits in the county was 
determined using the Tennessee Hospital Discharge Database System (HDDS) (https://
health.state.tn.us/statistics/specialprojects.htm#hdds)(55), which receives information from 
UB-92 (HCFA-1450) forms on all inpatient discharges and other selected patient visits from 
Tennessee hospitals. Each form contains information on patient diagnoses, procedures 
performed on the patient, charges for services provided, and selected patient demographics. 
Estimated Davidson County-based population rates were extrapolated from the study by 
multiplying the proportion of rhinovirus positive samples in our study hospitalized and ED 
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enrollees by the number of ARI hospital and ED visits in the county, and divided by the 
estimated county population, obtained from the CDC website, vintage release of the 
bridged-race estimates (http://www.cdc.gov/nchs/nvss/bridged_race.htm)(56). Population-
based rates were estimated only for Davidson County because this county contributed the 
majority of the samples and population data was readily available. Data were separated by 
county for population-based rate estimates; however, other analyses included data from all 
participating counties to maximize power.
Key disease outcomes of interest included hospitalization and obstructive wheezing illness 
(medical record documentation of physician-diagnosed asthma, COPD, or patient reported 
wheezing). We tested the association between rhinovirus detection and study outcomes 
using logistic regression, both with and without covariate adjustment. Rhinovirus status was 
categorized into 3 levels: rhinovirus positive only (no other virus co-detected), rhinovirus 
plus other study virus positive, and rhinovirus negative. This definition provided a clean 
comparison of rhinovirus positive samples that lack co-detection to study virus negative 
samples (negative for rhinovirus, influenza, MPV, and RSV). Multinomial logistic 
regression was used to model viral status as a function of disease outcomes both with and 
without covariate adjustment. A similar subset analysis (both with and without covariate 
adjustment) was conducted among rhinovirus-A and rhinovirus-C positive samples. Due to 
sample size restrictions, the subset analysis of rhinovirus (A and C) only adjusted for age, 
sex, and smoking. A separate logistic regression model was used to evaluate associations 
between all potential confounders and hospitalization in the subset population of rhinovirus 
positive samples (A, B, C, and non- sequenced samples). Odds ratios and corresponding 
95% confidence intervals are reported for all models.
Biologically relevant covariates chosen a priori included age, sex, smoking status (current 
smoker, lives with smoker, and never or previously smoked), public insurance, cardiac 
disease, supplemental oxygen use, respiratory disease (including asthma, COPD, other), and 
chronic steroid use (use of chronic oral steroids). The age variable was used to model a 
restricted cubic spline with four knots. Multinomial logistic regression was used to model 
viral status as a function of wheezing or hospitalization in a multivariable model, adjusting 
for covariates. This model provides an estimated odds ratio for each variable in the model 
for comparing the odds of rhinovirus-positive only versus virus negative, and for comparing 
the odds of rhinovirus plus other virus positive versus virus negative. The model provides 
both sets of odds ratios in one comprehensive model, which is more efficient than fitting two 
separate logistic regression models.
Secondary analyses were conducted with rhinovirus status as a binary variable 
corresponding to either rhinovirus-positive or rhinovirus-negative. Models with this variable 
included additional covariates for other viruses such as RSV, MPV, and influenza, in efforts 
to account for any co-infections in the evaluation of the association of rhinovirus with 
disease severity.
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Subjects were enrolled from December 2008 through May 2010. There were a total of 2351 
specimens available for testing. Four hundred seventy-two (20.1%) were from patients in the 
ED, 1231 (52.4%) from hospitalized subjects and 648 (27.6%) from clinic outpatients.
Two hundred and forty seven of the 2351 specimens (10.5%) tested positive for rhinovirus. 
Six samples represented co-detection with another virus, including three with influenza, one 
with RSV, and one with MPV. There were 1628 samples available for testing from 
Davidson County residents alone.
In Davidson County, rhinovirus was associated with 11.8% of ED visits, 8.9% of 
hospitalizations, and 14.1% of outpatient visits, translating to 6.9 ED visits and 3.0 
hospitalizations per 1000 adults per year (Table 1). Among the 180 Davidson County 
residents who tested positive for rhinovirus, 46.6% had rhinovirus A, 3.8% rhinovirus B, 
24.4% rhinovirus C, and 25% had rhinovirus that could not be sequenced. Rates by site are 
listed in Table 1. (See Supplemental Figure 1.)
Demographic factors among virus positive subjects enrolled in all 12 Tennessee counties 
were also examined. Table 2 compares features of rhinovirus-positive only and other virus 
positive (influenza, MPV, or RSV) subjects. The six co-detections were omitted from 
analyses comparing clinical symptoms. Compared to rhinovirus-positive and other virus 
positive, those with no study virus detected were more likely to be male (p=0.04), older 
(p<0.001), and non-smokers (p<0.001).
Rhinovirus A was the most common species detected in all settings (46.2%), followed by 
those not sequenced (27.1%), C (21.5%), and B (5.3%). The proportion of samples with 
rhinovirus significantly differed throughout the 18-month duration of the study (p < 0.001; 
Fig1a), however when the seasonal patterns of rhinovirus A and rhinovirus C were 
compared, there was not a statistically significant difference by species during the 18-month 
study period (p = 0.15; Fig 1b). Prevalence of rhinovirus A peaked during September 2009 
(Fig 1a), and rhinovirus C showed similar prevalence throughout the study (Fig 1b).
Rhinovirus and hospitalization
Those with rhinovirus only detected were less likely to be hospitalized than seen in the 
outpatient setting, compared to those with no virus detected (OR: 0.58, CI: 0.41, 0.83; 
Figure 2a). Patients positive for other viruses also had decreased odds for hospitalization, 
but this association was not statistically significant (OR: 0.8, CI: 0.56, 1.16; Figure 2a). For 
the subset analysis of rhinovirus species, there was not a significant association between 
rhinovirus A or rhinovirus C and hospitalization (OR: 0.81, CI: 0.39, 1.69, p = 0.57) after 
adjusting for age, smoking status and sex. However, neither of the confidence intervals for 
other viruses or rhinovirus A/C ruled out clinically meaningful odds ratios.
Rhinovirus and wheeze
Rhinovirus positive subjects had greater odds of wheezing compared to virus negative 
subjects (OR: 1.7, CI: 1.23, 2.35; Fig 3a), after adjusting for covariates described above 
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(p<0.001). Subjects who were positive for other viruses also had increased odds of wheeze 
(OR: 2.38, CI: 1.70, 3.34) compared to virus negative subjects. In the multivariable model, 
other variables associated with wheezing included smoking status [p<0.001, current smoker 
(OR: 1.73, CI: 1.36, 2.20) and lives with smoker (OR: 1.40, CI: 1.02, 1.93)], and underlying 
chronic respiratory disease (OR: 3.68, CI: 2.88, 4.70, p < 0.001; Fig 3). There was not a 
significant association between rhinovirus species (A versus C) and wheezing (OR: 1.44, CI: 
0.68, 3.08), though the precision of the CI did not rule out meaningful odds ratios.
Risk factors for rhinovirus among adults presenting with ARI/fever in various settings
Chronic smokers and those living with smokers were at increased odds of being rhinovirus-
positive. In the multinomial logistic regression model, smoking status (p < 0.001; Fig 4a), 
chronic respiratory disease (p = 0.016), and age (Fig 4b; p = 0.003), were significantly 
associated with increased odds of rhinovirus detection, after adjusting for age, sex, smoking 
status, public insurance, cardiac disease, supplemental oxygen use, respiratory disease, 
chronic steroid use, and living with children under the age of 18. Individuals who were 
currently smoking had 2.31-fold greater odds of having rhinovirus (CI: 1.68, 3.19) and those 
living with a smoker had 1.72-fold greater odds of being rhinovirus-positive (CI: 1.10, 2.67), 
compared to people who never or previously smoked (Fig 4a). Subjects with chronic 
respiratory disease had 1.61-fold greater odds of rhinovirus infection (CI: 1.17, 2.22) 
compared to patients without chronic respiratory illness. Although younger individuals were 
more likely to be infected with rhinovirus (Fig 4c), we were not able to find a significant 
association of rhinovirus status and living with children under the age of 18 (p = 0.28; Fig 
4a).
Neither current smokers (OR: 1.18, CI: 0.84, 1.67) nor those living with a smoker (OR: 
1.23, CI: 0.79, 1.93) significantly increased odds of being other virus-positive compared to 
patients who never or previously smoked (Fig 4b), though the CI did not rule out 
meaningful odds ratios. Chronic respiratory disease was not significantly associated with 
being other virus-positive (OR: 1.03, CI: 0.73, 1.46). In contrast, chronic oral steroid use 
was associated with greater odds of other virus-positive (OR: 1.52, CI: 1.03, 2.25) relative to 
virus negative status (Fig 4b).
Secondary analyses of rhinovirus as a binary variable (rhinovirus positive, rhinovirus 
negative) with adjustment for other viruses did not reveal any notable findings beyond what 
is reported above. Results of these models are not shown.
Discussion
Our findings confirm that rhinovirus is prevalent in US adults presenting with acute 
respiratory illness or fever to the hospital, ED, or outpatient clinics. The rhinovirus-
associated rate of hospitalization was 3 per 1000 per year, and the rate of ED visits was 6.9 
per 1000 per year. Proportions of rhinovirus-associated ARI in Davidson County were 8.9% 
of hospitalizations, 11.8% of ED visits, and 14.1% of outpatient visits. Few of these 
represented co-detections with other common respiratory viruses. There have been few 
prospective studies on rhinovirus in adults, and no known published rates of rhinovirus-
associated hospitalization or ED visits in US adults. In a 2011 study, the proportion of 
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rhinovirus in adults and children hospitalized with ARI in Thailand was found to be to be 
16%, compared with 9.6% of outpatients(57). However the outpatient population was a 
convenience sample without other clinical data, and patients were mostly hospitalized. Thus, 
the proportion of rhinovirus may be different in the general population seeking medical care. 
A few other studies have reported proportion of adults with rhinovirus-associated ARI to be 
from 4%-23%; however these either examined specimens that had tested negative for other 
viruses(58), had small sample sizes(59), or selected for subjects presenting with fever(41, 
60), thus likely underestimating rhinovirus prevalence. The rates of rhinovirus-associated 
hospitalization we detected were generally lower than those reported in a similarly-designed 
study of young children in this same geographic region (5 per 1000/year overall for children 
aged 0-5 years)(61). This is consistent with the fact that respiratory virus detection, in 
general, is less common in adults compared with children. Typical HRV detection after 
initial infection persists 7-11 days, rarely up to 28 days in the immunocompetent host(62). 
The aforementioned Thai study found increased prevalence of rhinovirus in children 
compared to adults(57) and another study found that rhinovirus-associated symptoms were 
more severe among children when compared with adults(63). Adults have likely had prior 
exposure to more rhinoviruses, hence it is likely they become symptomatic less often and 
when symptomatic shed less virus than children. When infected with rhinovirus, it is likely 
to be the complications associated with ARI and underlying medication conditions that 
cause patients to seek care. It is possible that more adults in Davidson County had 
rhinovirus-associated ARI but did not present to any clinical setting for evaluation.
In studies published to date of adults and children with rhinovirus C, the proportion of 
rhinovirus attributable to rhinovirus C ranged from 8 to 81% (13, 15, 20, 32, 63-73). In our 
study, the proportion of rhinovirus C was 1.9% in hospitalized, 3.0% ED, and 3.8% in 
outpatient settings. A recent US study found, among 72 adults seeking care with rhinovirus-
associated respiratory illness, those with RV-A or RV-B had greater illness severity; 
however, this association disappeared after controlling for confounders(42). While overall 
rhinovirus peaked in September, rhinovirus C displayed no clear seasonal pattern. One 
longitudinal pediatric study in the same region over a 21-year period found HRV-C to be 
more prevalent during winter(74), as did a surveillance study in the Middle East(72). 
However, others have found rhinovirus C to circulate with a similar bimodal peak to that 
identified for the HRVs in general(32, 72, 75), or to be evenly distributed year-round(71). 
Lee et al. found that single rhinovirus infections (excluding co-detections with other 
common respiratory viruses like RSV and influenza) were 5- to 10-fold more likely to cause 
moderate to severe illness during winter months compared with summer, despite increased 
overall rhinovirus prevalence during spring and fall(76) suggesting the need to further study 
correlations between season and symptom severity.
Several demographic and clinical variables were significantly associated with hospitalization 
and wheezing. In our study, hospitalization (versus outpatient visit) was more likely in 
males, older subjects, those taking chronic oral steroids, and those who used supplemental 
oxygen at home. Hospitalization was less likely among subjects with rhinovirus compared to 
those subjects that were study virus negative, perhaps due to the fact that patients were 
hospitalized with other comorbid conditions. Wark et al. found that viral and bacterial 
infection in acute asthma and COPD increased length of hospitalization as well as risk for 
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hospital readmission(77). However, that study only enrolled adults hospitalized with acute 
asthma or COPD, and there were no outpatients for assessment. Another study found that 
rhinovirus infections were frequently followed by secondary bacterial infections in adults 
with COPD, with sputum viral load peaking at day 5-9 and bacterial load on day 15(78). Our 
study did not test for bacterial respiratory infections. Thus, it is possible that patients had 
milder respiratory symptoms with rhinovirus, followed by prolonged or more severe 
symptoms with subsequent bacterial infection prompting clinical care, or that patients 
presented with a bacterial infection and incidentally were positive for rhinovirus. In general, 
in this study, rhinovirus was not associated with severe disease unless there was respiratory 
compromise at baseline.
Wheezing outcome was more likely in patients who had rhinovirus, another virus, 
underlying respiratory disease, or increasing age up to 45 years. A previous study examining 
hospitalized patients with severe asthma exacerbations described differing proportions of 
certain demographic and clinical factors by age group(79). In that study, younger patients 
hospitalized with acute asthma exacerbation were more likely to have pets and smoke; 
middle-aged patients had high rates of aspirin intolerance; and older patients were more 
likely to have hypertension, cardiac disease, diabetes, and COPD. Continuous inhaled 
corticosteroid use increased with age category(79). Our study was designed differently, with 
enrollment of patients seeking care for any ARI/fever in various clinical settings. We did not 
collect information on continuous inhaled corticosteroids. McCullough et al. found no 
differences in RV species detection among 72 adults with rhinovirus-associated respiratory 
symptoms and underlying pulmonary comorbidities (primarily asthma/COPD), nor were 
pulmonary comorbidities associated with rhinovirus-associated illness severity in that 
study(42). Other studies of asthma exacerbations in children and adults(22, 23, 26, 32-38) 
clearly show an association with rhinovirus detection. Of interest in our study, with 
increasing age beyond 45 years, wheezing was a less likely diagnosis, perhaps related to 
other diseases increasing in prevalence with age.
Because rhinovirus was the most common virus detected among these adults seeking clinical 
care, and because asymptomatic or mild infection with rhinovirus also occurs(28, 80), we 
sought to determine factors that may predispose a patient to present with symptoms from 
rhinovirus. Notably, having rhinovirus detected during an ARI/fever visit was more likely 
among those who smoked or lived with smokers, those with underlying respiratory disease, 
and adults around the age of 60. One smaller study found that adults hospitalized with a 
rhinovirus-associated asthma exacerbation were more likely to be smokers(25). Proud et al. 
recently studied primary human bronchial epithelial cells and identified a potential 
mechanism for this relationship: cigarette smoke modulated the expression of rhinovirus-
induced airway epithelial host defense genes(81). Another group also found that cigarette 
smoke decreased innate responses of epithelial cells to rhinovirus infection, further 
supporting our results. Hudy recently reported that cigarette smoke exposure specifically 
reduces chromatin accessibility and inhibits viral signaling via NF-κB, IRF-1, STAT-1, and 
MDA5, concluding that cigarette smoke exposure can simultaneously modulate multiple 
pathways linked to innate immune responses to rhinovirus infection(82). One study of the 
elderly found that smoking and chronic medical conditions were risk factors for lower 
respiratory complications with rhinovirus(83). Our study confirms these findings in a large-
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scale, prospective study of adults presenting to the hospital, ED, or clinics with ARI. With 
regards to the elderly population, it has recently been reported that RSV and MPV 
symptomatically infect this group with rates similar to that for influenza(44). We now report 
that rates of rhinovirus-associated ARI in this population are also prominent in this age 
group and are particularly prevalent among those who smoke or live with smokers, those 
with underlying respiratory disease, and those approximately 60 years old. These groups 
should be targeted with interventions.
Limitations
Despite the strengths of this large, multi-site, prospective study, there are limitations. First, 
we did not test for bacterial respiratory tract infection. However, we tested for multiple 
common respiratory viruses. Next, information on inhaled corticosteroids was not collected 
because the study was originally designed for influenza surveillance and not specifically for 
asthma. The timing of symptom onset to enrollment and sample collection varied between 
subjects. Finally, this study represents a single geographic region over a one-and-a-half year 
period encompassing the novel influenza A H1N1 pandemic, thus rates may not be 
representative of all years and regions. However, we enrolled patients from 12 counties and 
the proportions of rhinovirus detected were similar to other reports that did not calculate 
population-based rates. Our rate calculations relied on the assumption that the percent of 
infections in persons we enrolled would be similar to percent in persons with acute 
respiratory illness ED and hospital discharge diagnoses. Despite these limitations, studies 
that use direct patient testing to estimate rates are needed to help define the burden of 
disease and focus future preventive and treatment measures.
In conclusion, we estimate that rates of hospitalization or ED visits associated with 
rhinovirus in Davidson County, TN were 3.0 and 6.9, respectively per 1000 people per year. 
We found that rhinovirus positive subjects were more likely to wheeze compared to virus 
negative subjects. Finally, smoking and living with a smoker increased the odds of 
rhinovirus detection. This evidence suggests that there are modifiable factors that may 
decrease the odds of rhinovirus-associated clinical visits.
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Rhinoviruses are commonly detected among adults with acute respiratory illness 
presenting for medical care in the acute clinical setting. Certain factors are associated 
with rhinovirus detection in this population.
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Figure 1. Seasonal prevalence
Among adults seeking care for respiratory illness or fever, rhinovirus (RV) detection differs 
significantly by month. A) When all rhinovirus-associated episodes are examined, virus 
prevalence is highest during August and September of 2009 (p < 0.001). This graph shows 
the probability of a rhinovirus-positive ARI. B) When probability of rhinovirus C ARI is 
compared to rhinovirus A, peaks of rhinovirus A are seen during August 2009 and April 
2010; however, differences are not statistically significant (p = 0.16). Shaded regions 
represent 95% confidence intervals.
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Virus status does not account for hospitalization of subjects. A) Odds ratios and confidence 
intervals of hospitalized subjects compared to outpatients and emergency department visits 
adjusted for viral status (p = 0.009), sex (p < 0.001), smoking status (p = 0.05), public 
insurance (p < 0.001), cardiac disease (p < 0.001), oxygen use (p < 0.001), chronic 
respiratory disease (p < 0.001), chronic steroid use (p < 0.001), and B) age (p < 0.001). 
Older adults had an increased probability of hospitalization.
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Rhinovirus (RV) status is associated with increased odds of wheezing. A) Odds ratios and 
confidence intervals of subjects with wheeze compared to those without wheeze are shown, 
adjusted for rhinovirus (p < 0.001), other virus positive (Influenza, metapneumovirus, 
respiratory syncytial virus; p < 0.001), sex, smoking status (p < 0.001), public insurance, 
cardiac disease, oxygen use, chronic respiratory disease (p < 0.001) and chronic steroid use. 
B) Age is also associated with wheeze (p < 0.001), the probability of wheeze increases with 
age until approximately 45 years old, then gradually decreases.
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Figure 4. Rhinovirus-positive and ‘other virus’ positive subjects
A) Smoking status (p < 0.001) and chronic respiratory disease (p = 0.02) increase odds of 
being rhinovirus (RV) positive compared to being virus negative. B) Odds ratios for subjects 
that are ‘other virus’ positive compared to virus negative, and C) probability of being 
rhinovirus-positive (dashed line) or ‘other virus’ positive (solid line) with age (P = 0.003). 
Odds ratios (midpoint) and confidence intervals are shown. Values were adjusted for age, 
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race, smoking status, public insurance, cardiac disease, oxygen use, chronic respiratory 
disease, chronic steroid use, and living with children under the age of 18.
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Table 1
Number of rhinovirus-positive subjects by site from Davidson County.
Emergency Department % (n) [rate] Inpatient % (n) [rate] Outpatient % (n)
Davidson County
* n =364 n = 795 n =469
Rhinovirus-positive 11.8% (43) [6.9] 8.9% (71) [3.0] 14.1% (66)
Rhinovirus A 4.9% (18) [2.78] 4.7% (37) [1.49] 6.2% (29)
Rhinovirus B 0.8% (3) [0.46] 0.2% (2) [0.08] 0.4% (2)
Rhinovirus C 3.0% (11) [1.70] 1.9% (15) [0.60] 3.8% (18)
Not sequenced 3.0% (11) [1.70] 2.1% (17) [0.68] 3.6% (17)
*
Percents given, with counts in parentheses and rates in bold (rate/1000 subjects/year). Rates were only available for the emergency department 
and inpatient settings in Davidson County.













Miller et al. Page 22
Table 2
Demographic features of human rhinovirus-positive, other virus positive and rhinovirus-negative subjects, 
excluding co-infections.
Rhinovirus positive % (n = 
252)
Other virus positive % (n = 
259)
Virus negative % (n = 1840) p value
Male 34.0 % (86) 34.0% (89) 40.0% (746) 0.04
Race 0.29
        Black 29.7% (74) 24.1% (62) 24.3% (508)
        White 63.1% (1573) 68.9% (177) 68.7% (1437)
        Hispanic/other 7.2% (18) 7.0% (18) 5.9% (123)
Public insurance 42.0% (98) 38.0% (84) 46.0% (695) 0.11
Age 29 45 59 30 47 62 37 52 65 < 0.001
Lives with children < 18 38.0% (96) 35.0% (90) 30.0% (554) 0.08
Smoking status <0.001
        Current smoker 41.0% (102) 28.0% (73) 25.0% (458)
        Lives with smoker 14.0% (36) 13.0% (33) 11.0% (206)
* Percent and total number of subjects shown, median and quartiles given for ‘age’. Unadjusted p-values determined using Pearsons test, except for 
‘age’, which was determined using a Wilcoxon test.
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